EXOZYMES INC. (EXOZ) › Cash & EquivalentsEXOZYMES INC. (EXOZ) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2023: $66.5K2024: $9.72M2025: $3.04M$3.04M2023Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$3.04M-68.7%2024$9.72M+14508.3%2023$66.5K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share